HDAC9 and neoplasm: Expressions of fewer genes are induced by MGCD0103, a benzamide HDAC inhibitor, than are induced by nonselective hydroxamate HDAC inhibitors, yet the efficacy of MGCD0103 in preclinical tumor models is maintained or even elevated 10.